We can now customize cancer treatments, tumor by tumor - MIT Technology Rev

The first time someone pitched Genentech’s senior leadership on a personalized cancer vaccine, it did not go well. “I thought there was going to be a riot,” Ira Mellman, then Genentech’s head of research oncology, recalls.

We can now customize cancer treatments, tumor by tumor - MIT Technology Rev